SBI Securities’s ABVC BioPharma ABVC Stock Holding History

SBI Securities’s Portfolio ABVC Stock Details ABVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1	Buy	+1	New	+$1	﹤0.01%	4104
2025 Q3	–	Sell	-483	Closed	-$1.08K	–	4186
2025 Q2	$1.08K	Buy	483 +23	+5%	+$31	﹤0.01%	2648
2025 Q1	$488	Sell	460 -202	-31%	-$123	﹤0.01%	2881
2024 Q4	$391	Buy	+662	New	+$369	﹤0.01%	2985

SBI Securities's ABVC Position: Q3 2026 in Review

SBI Securities opened a new position in ABVC BioPharma (ABVC) in Q3 2026: 1 share worth $1. The stake represents ﹤0.01% of the portfolio and ranks #4104 among its holdings. This is a return to the name: SBI Securities previously reported a position in ABVC as recently as Q2 2025.

SBI Securities first reported a position in ABVC in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.08K in Q2 2025. 1 fund tracked by Wall St. Rank holds ABVC as of Q3 2026.

SBI Securities held 1 share of ABVC BioPharma worth $1 as of Q3 2026.
ABVC BioPharma was a new SBI Securities position in Q3 2026.
ABVC BioPharma made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #4104 holding.
SBI Securities first reported a position in ABVC BioPharma in Q4 2024 and has held it in 4 quarters since.
SBI Securities's ABVC BioPharma position peaked at $1.08K in Q2 2025.
1 fund tracked by Wall St. Rank held ABVC BioPharma as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.